D.
4576.TD. Western Therapeutics Institute, Inc. Price (4576.T)
Stock Price
Market Cap
Fetching Data...
Enterprise Value
Fetching Data...
Volume
Fetching Data...
Shares Outstanding
35,118,450
(10.5047)%Income Statement Summary
| Revenue | |
| Cost of Revenue | |
| Gross Profit | |
| Operating Expenses | |
| Operating Income | |
| Other Expenses | |
| Net Income |
Income Statement
D. Western Therapeutics Institute, Inc.Currency: JPY
| YEAR | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||||||||
| Revenue |
580,527,000.00
+0% |
355,586,000.00
-39% |
414,424,000.00
+17% |
448,100,000.00
+8% |
428,364,000.00
-4% |
471,580,000.00
+10% |
|||||||||||||
| Cost of Revenue | |||||||||||||||||||
| Cost of Revenue | 70,045,000.00 | 17,019,000.00 | 20,099,000.00 | 27,566,000.00 | 36,666,000.00 | 46,843,000.00 | |||||||||||||
| Gross Profit | |||||||||||||||||||
| Gross Profit |
510,482,000.00
+0% |
338,567,000.00
-34% |
394,325,000.00
+16% |
420,534,000.00
+7% |
391,698,000.00
-7% |
424,737,000.00
+8% |
|||||||||||||
| Gross Profit Ratio | (0.88%) | (0.95%) | (0.95%) | (0.94%) | (0.91%) | (0.90%) | |||||||||||||
| Operating Expenses | |||||||||||||||||||
| Research and Development | 249,362,000.00 | 350,535,000.00 | 316,161,000.00 | 469,564,000.00 | 930,506,000.00 | 1,367,769,000.00 | |||||||||||||
| General and Administrative | 80,000,000.00 | 126,000,000.00 | 110,000,000.00 | 103,000,000.00 | 106,000,000.00 | 0.00 | |||||||||||||
| Selling, General & Admin... | 143,805,000.00 | 253,000,000.00 | 248,000,000.00 | 255,000,000.00 | 258,000,000.00 | 266,565,000.00 | |||||||||||||
| Selling & Marketing Exp... | 107,000,000.00 | 127,000,000.00 | 138,000,000.00 | 152,000,000.00 | 152,000,000.00 | 0.00 | |||||||||||||
| Depreciation and Amortiz... | 44,192,000.00 | 44,157,000.00 | 45,259,000.00 | 46,366,000.00 | 48,721,000.00 | 49,329,000.00 | |||||||||||||
| Other Expenses | 0.00 | -3,710,000.00 | 127,000.00 | -8,336,000.00 | 1,750,000.00 | 1,000.00 | |||||||||||||
| Total Operating Expenses | 393,167,000.00 | 604,245,000.00 | 565,973,000.00 | 726,445,000.00 | 1,190,256,000.00 | 1,634,335,000.00 | |||||||||||||
| Cost and Exponses | 463,212,000.00 | 621,264,000.00 | 586,072,000.00 | 754,011,000.00 | 1,226,922,000.00 | 1,681,178,000.00 | |||||||||||||
| Operating Income | |||||||||||||||||||
| Operating Income |
117,315,000.00
+0% |
-265,679,000.00
-326% |
-171,649,000.00
-35% |
-305,912,000.00
+78% |
-798,558,000.00
+161% |
-1,209,598,000.00
+51% |
|||||||||||||
| Operating Income Ratio | (0.20%) | (-0.75%) | (-0.41%) | (-0.68%) | (-1.86%) | (-2.56%) | |||||||||||||
| Other Income and Exp... | |||||||||||||||||||
| Interest Income | 5,000,000.00 | 127,000.00 | 21,000.00 | 25,000.00 | 10,000.00 | 0.00 | |||||||||||||
| Interest Expenses | 5,875,000.00 | 4,728,000.00 | 4,424,000.00 | 3,147,000.00 | 2,490,000.00 | 0.00 | |||||||||||||
| Total Other Income/Exp... | -7,737,000.00 | -23,848,000.00 | 11,938,000.00 | -134,355,000.00 | -28,245,000.00 | -79,112,000.00 | |||||||||||||
| EBITDA | |||||||||||||||||||
| EBITDA | 161,507,000.00 | -240,639,999.00 | -110,028,000.00 | -390,752,000.00 | -775,591,000.00 | -1,160,268,000.00 | |||||||||||||
| EBITDA ratio | (0.28%) | (-0.68%) | (-0.27%) | (-0.55%) | (-1.81%) | (-2.46%) | |||||||||||||
| Income Before Tax | |||||||||||||||||||
| Income Before Tax | 109,578,000.00 | -289,527,000.00 | -159,711,000.00 | -440,267,000.00 | -826,803,000.00 | -1,288,710,000.00 | |||||||||||||
| Income Before Tax Ratio | (0.19%) | (-0.81%) | (-0.39%) | (-0.98%) | (-1.93%) | (-2.73%) | |||||||||||||
| Income Tax Expense | |||||||||||||||||||
| Income Tax Expense | 1,595,000.00 | 1,595,000.00 | 1,595,000.00 | 1,595,000.00 | 1,595,000.00 | 1,595,000.00 | |||||||||||||
| Net Income | |||||||||||||||||||
| Net Income | 133,202,000.00
+0% |
-276,104,000.00
-307% |
-148,995,000.00
-46% |
-429,685,000.00
+188% |
-812,411,000.00
+89% |
-1,290,305,000.00
+59% |
|||||||||||||
| Net Income Ratio | (0.23%) | (-0.78%) | (-0.36%) | (-0.96%) | (-1.90%) | (-2.74%) | |||||||||||||
| Earning Per Share | |||||||||||||||||||
| Basic EPS | 5.07 | -10.16 | -5.08 | -14.50 | -25.56 | -36.74 | |||||||||||||
| Diluted EPS | 5.07 | -10.16 | -5.08 | -14.50 | -25.56 | -36.74 | |||||||||||||
| Share Outstanding | |||||||||||||||||||
| Basic Share Outstanding | 26,275,200.00 | 27,171,914.00 | 29,333,698.00 | 29,639,914.00 | 31,780,063.00 | 35,118,450.00 | |||||||||||||
| Diluted Share Outstanding | 26,275,200.00 | 27,171,914.00 | 29,333,698.00 | 29,639,914.00 | 31,780,063.00 | 35,118,450.00 | |||||||||||||